Site Search
410 result(s) found for “ adaptive therapy”
-
Proton Therapy vs. Traditional Radiation for Head & Neck Cancer: What the Latest Evidence Means for Your Patients
Explore the latest evidence comparing proton therapy and IMRT for head and neck cancer, including survival, toxicity and quality-of-life findings and...
-
Are Cellular Therapies the New Frontier in Cancer Treatment?
Moffitt experts discuss the latest in cellular therapy at annual Research Innovation event
-
Combo of Three Therapies Shows Promise for Advanced Melanoma
Triplet therapy offers hope for stage 4 melanoma patients including th 3D rendering of PD-1 and PD-1L protein molecules on T cell and cancer cells...
-
Recent FDA Approvals for New Uses of Cellular Therapies
Recent advancements in cellular therapies, such as CAR T and TILs, have led to new FDA approvals for expanded uses.
-
MRIdian® MRI-Guided Radiation Therapy Shows Positive Results in Treatment of Ultracentral/Central Lung Tumors
Moffitt researchers conducted a study using MRI-guided SBRT/ hypofractionated radiation therapy with image-guided real-time tracking and automatic...
-
19MA016N Immunotherapy: Combination Therapy Using BRAF Inhibitors with Immunotherapy to Treat RAS Mutant Driven Cancers
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe Innovation Dedicated to supporting patients every step of the way, with...
-
Identification of Targetable Gene Fusions Present in KRASWT Pancreatic Adenocarcinoma and the Response to Targeted Therapy
Study shows Oncogene fusions are present in KRASWT pancreatic adenocarcinomas at an increased frequency when compared with KRASMUT pancreatic...
-
New Study Highlights CAR T-cell Therapy Success for Lymphoma When Used as Standard of Care
Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data
-
Newly-Approved Therapy Provides Improved Quality of Life for Patients with Advanced Metastatic Midgut Neuroendocrine Tumors
Study published in the Journal of Clinical Oncology shows patients treated with Lutathera® have prolonged functional health-related quality of life...
-
Moffitt Cancer Center Celebrates 2 Milestones at SPEROS FL
The global research park will treat its first patient in January 2026